Founders Capital Management (Texas)’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$64.7K Hold
512
0.03% 133
2026
Q1
$71.4K Sell
512
-300
-37% -$42K 0.03% 115
2025
Q4
$99.7K Hold
812
0.05% 88
2025
Q3
$90.1K Hold
812
0.05% 91
2025
Q2
$90K Sell
812
-200
-20% -$21.3K 0.05% 90
2025
Q1
$113K Hold
1,012
0.07% 72
2024
Q4
$93.5K Hold
1,012
0.06% 83
2024
Q3
$84.8K Hold
1,012
0.05% 92
2024
Q2
$69.4K Hold
1,012
0.05% 109
2024
Q1
$74.1K Hold
1,012
0.05% 111
2023
Q4
$82K Hold
1,012
0.06% 97
2023
Q3
$75.8K Hold
1,012
0.06% 94
2023
Q2
$78K Hold
1,012
0.06% 107
2023
Q1
$84K Hold
1,012
0.06% 99
2022
Q4
$87K Sell
1,012
-100
-9% -$7.92K 0.07% 95
2022
Q3
$69K Hold
1,112
0.06% 106
2022
Q2
$69K Buy
1,112
+112
+11% +$6.93K 0.05% 106
2022
Q1
$73K Hold
1,000
0.05% 101
2021
Q4
$73K Hold
1,000
0.05% 101
2021
Q3
$70K Hold
1,000
0.05% 101
2021
Q2
$69K Hold
1,000
0.05% 104
2021
Q1
$65K Buy
1,000
+100
+11% +$6.45K 0.05% 96
2020
Q4
$52K Buy
+900
New +$54.3K 0.04% 100
2020
Q1
$67K Buy
900
+300
+50% +$20.7K 0.07% 74
2019
Q4
$39K Hold
600
0.03% 128
2019
Q3
$38K Hold
600
0.03% 128
2019
Q2
$41K Hold
600
0.04% 127
2019
Q1
$39K Buy
600
+200
+50% +$13.3K 0.04% 131
2018
Q4
$25K Hold
400
0.03% 152
2018
Q3
$31K Hold
400
0.03% 144
2018
Q2
$28K Hold
400
0.02% 153
2018
Q1
$30K Hold
400
0.03% 174
2017
Q4
$29K Hold
400
0.02% 178
2017
Q3
$32K Hold
400
0.03% 162
2017
Q2
$28K Buy
400
+100
+33% +$6.65K 0.02% 174
2017
Q1
$20K Buy
+300
New +$21.1K 0.02% 207

Other funds holding GILD

Founders Capital Management (Texas)'s GILD Position: Q2 2026 in Review

Founders Capital Management (Texas) held its Gilead Sciences (GILD) position steady in Q2 2026 at 512 shares worth $64.7K. The position accounts for 0.03% of the portfolio, ranked #133.

Founders Capital Management (Texas) first reported a position in GILD in Q1 2017 and has held it in 36 quarters since. The position peaked at $113K in Q1 2025. 690 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Founders Capital Management (Texas) held 512 shares of Gilead Sciences worth $64.7K as of Q2 2026.
  • Founders Capital Management (Texas) left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up 0.03% of Founders Capital Management (Texas)'s portfolio in Q2 2026, its #133 holding.
  • Founders Capital Management (Texas) first reported a position in Gilead Sciences in Q1 2017 and has held it in 36 quarters since.
  • Founders Capital Management (Texas)'s Gilead Sciences position peaked at $113K in Q1 2025.
  • 690 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Founders Capital Management (Texas)'s 13F filing for Q2 2026, filed 21 Jul 2026.